1,1'-Carbonyldiimidazole → HCID 68843504, 화합물
반응식
[F:1][C:2]1[CH:3]=[C:4]([CH:29]=[C:30]([F:32])[CH:31]=1)[O:5][CH2:6][CH2:7][N:8]([CH3:28])[CH2:9][CH2:10][CH2:11][NH:12][CH2:13][C@@H:14]([C:16]1[C:25]2[C:20](=[CH:21][CH:22]=[C:23]([O:26][CH3:27])[CH:24]=2)[N:19]=[CH:18][CH:17]=1)[OH:15].[C:33](N1C=CN=C1)(N1C=CN=C1)=[O:34]>C(Cl)Cl>[F:32][C:30]1[CH:29]=[C:4]([CH:3]=[C:2]([F:1])[CH:31]=1)[O:5][CH2:6][CH2:7][N:8]([CH3:28])[CH2:9][CH2:10][CH2:11][N:12]1[CH2:13][C@@H:14]([C:16]2[C:25]3[C:20](=[CH:21][CH:22]=[C:23]([O:26][CH3:27])[CH:24]=3)[N:19]=[CH:18][CH:17]=2)[O:15][C:33]1=[O:34]참가 물질
4
실험 절차
A mixture of (R)-2-(3-{[2-(3,5-difluoro-phenoxy)-ethyl]-methyl-amino}-propylamino}-1-(6-methoxy-quinolin-4-yl)-ethanol (105 mg, 0.24 mmol), DMAP-(38 mg, 0.31 mmol), 1,1′-carbonyldiimidazole (51 mg, 0.31 mmol) and methylene chloride stabilised on amylene (4 ml) was stirred at room temperature for 16 hours. The solvent was concentrated and the residue was chromatographed on silicagel eluting with methylene chloride-methanol (94-6) to give (R)-3-(3-{[2-(3,5-difluoro-phenoxy)-ethyl]-methyl-amino)-propyl)-5-(6-methoxy-quinolin-4-yl)-oxazolidin-2-one (70 mg, 62%).
후처리
- concentrationThe solvent was concentrated
- customthe residue was chromatographed on silicagel
- washeluting with methylene chloride-methanol (94-6)
출처 및 근거
- ORD 기록
- ord-886f468c26714823bf32312429299622
- 출처 데이터셋
- uspto-grants-2009_02
- 특허 번호
- US07491714B2
반응 노트
불러오는 중…